ID   RC-1 [Human renal cell carcinoma]
AC   CVCL_LF74
DR   Wikidata; Q54949368
RX   PubMed=3455754;
CC   Characteristics: Produces EPO.
CC   Doubling time: 48 hours (Note=At 37th passage), 29 hours (Note=At 40th passage), 24 hours (Note=At 53th passage) (PubMed=3455754).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 29-06-23; Version: 7
//
RX   PubMed=3455754; DOI=10.1073/pnas.83.1.165; PMCID=PMC322812;
RA   Sherwood, Judith B.
RA   Shouval, Daniel
RT   "Continuous production of erythropoietin by an established human renal
RT   carcinoma cell line: development of the cell line.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:165-169(1986).
//